Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.786 USD | +0.77% | -68.47% | -75.48% |
May. 15 | Virpax Prices Public Offering of Shares, Warrants; Shares Tumble | MT |
May. 15 | Top Premarket Decliners | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-75.48% | 914K | |
+33.07% | 49.46B | |
+2.02% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+12.08% | 26.61B | |
-22.58% | 18.64B | |
+8.32% | 13.16B | |
+30.32% | 12.55B | |
+24.00% | 12.1B |
- Stock Market
- Equities
- VRPX Stock
- News Virpax Pharmaceuticals, Inc.
- Virpax Pharmaceuticals, Inc. Appoints Michèle C. Linde as the Executive Vice President, General Counsel and Corporate Secretary